Congenital central hypothyroidism occurs either in isolation or in conjunction with other pituitary hormone deficits. Using exome and candidate gene sequencing, we identified 8 distinct mutations and 2 deletions in IGSF1 in males from 11 unrelated families with central hypothyroidism, testicular enlargement and variably low prolactin concentrations. IGSF1 is a membrane glycoprotein that is highly expressed in the anterior pituitary gland, and the identified mutations impair its trafficking to the cell surface in heterologous cells. Igsf1-deficient male mice show diminished pituitary and serum thyroid-stimulating hormone (TSH) concentrations, reduced pituitary thyrotropin-releasing hormone (TRH) receptor expression, decreased triiodothyronine concentrations and increased body mass. Collectively, our observations delineate a new X-linked disorder in which loss-of-function mutations in IGSF1 cause central hypothyroidism, likely secondary to an associated impairment in pituitary TRH signaling.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
NCBI Reference Sequence
The authors thank X.-H. Liao from the Refetoff laboratory (The University of Chicago, supported by US National Institutes of Health (NIH) grant DK15700) for measuring T4, T3, FT4I and TSH in mice, P. Scheiffele for the antibody to IGSF1 CTD and S. Kimmins (McGill University) and P. Bisschop (Academic Medical Center, University of Amsterdam) for human testis and pituitary RNA, respectively. We also thank H. Bikker, J.C. Moreno, A. Escudero, E. Aten, M. Losekoot, E. Endert, J.W.A. Smit, R.van Rijn and E.L. van Persijn-van Meerten for technical support and advice. We thank F.J. de Jong and Y. de Rijke for measuring serum inhibin B and AMH and for providing age references. We thank S. Tran and X. Zhou for assistance with collection of mouse serum samples. We acknowledge the help of N. Zwaveling, J. Gosen, E.J. Schroor, L.C.G. de Graaff and G. Radetti in providing clinical data. We acknowledge The Eastern Region Sequencing and Informatics Hub (see URLs), who undertook sequencing and preliminary bioinformatics analyses of data from the UK families. We thank the subjects and their families for participating. Our work was supported in part by a grant from the China Scholarship Council (to Y.S.); a National Sciences and Engineering Research Council (NSERC) Doctoral Research Award (to B.B.), NSERC Discovery Grant 341801-07 and a Fonds de la Recherche en Santé du Québec (FRSQ) Chercheur Boursier Senior Award (to D.J.B.); grants from the Wellcome Trust (095564 to N.S. and K.C.; WT077157/Z/05/Z to E.C. and J.K.W.; 084361, 078432 and 086545 to J.P.M.-B.), the National Institutes of Health Research Cambridge Biomedical Research Centre (to N.S. and K.C.) and the UK Medical Research Council (MRC; U117570590 to P.l.T.); a National Health and Medical Research Council of Australia Practitioner Fellowship (to T.M.E.D.); the Dutch Growth Research Foundation (D.G.D.B.); the Young Investigator grant of the Italian Ministry of Health and Istituto Auxologico Italiano IRCCS (GR-2008-1137632 to M.B.); and the Great Ormond Street Children's Hospital Charity (to M.T.D.).
Supplementary Figures 1–5, Supplementary Tables 1–6 and Supplementary Note
About this article
Genome Biology and Evolution (2019)